Literature DB >> 16093445

Septic shock after medical abortions with mifepristone (Mifeprex, RU 486) and misoprostol.

Sally Murray, Eric Wooltorton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093445      PMCID: PMC1188182          DOI: 10.1503/cmaj.050980

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii.

Authors:  Ralph P Miech
Journal:  Ann Pharmacother       Date:  2005-07-26       Impact factor: 3.154

2.  Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease.

Authors:  Christian Sinave; Geneviève Le Templier; Daniel Blouin; François Léveillé; Eric Deland
Journal:  Clin Infect Dis       Date:  2002-11-13       Impact factor: 9.079

Review 3.  The clinical spectrum of Clostridium sordellii bacteraemia: two case reports and a review of the literature.

Authors:  A Abdulla; L Yee
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

  3 in total
  4 in total

1.  Foot infection by Clostridium sordellii: case report and review of 15 cases in France.

Authors:  Philippe Bouvet; Jean Sautereau; Alain Le Coustumier; Francine Mory; Christiane Bouchier; Michel-R Popoff
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

2.  Requirements for germination of Clostridium sordellii spores in vitro.

Authors:  Norma Ramirez; Ernesto Abel-Santos
Journal:  J Bacteriol       Date:  2009-11-13       Impact factor: 3.490

3.  Off-label use of misoprostol in gynaecology.

Authors:  J V Turner; S Agatonovic-Kustrn; Hrg Ward
Journal:  Facts Views Vis Obgyn       Date:  2015-12-28

4.  Pain management of surgical abortion using transcutaneous acupoint electrical stimulation: An orthogonal prospective study.

Authors:  Zedong Wang; Yong Chen; Chong Chen; Liang Zhao; Pinjie Chen; Linchai Zeng; Wenxia Xie
Journal:  J Obstet Gynaecol Res       Date:  2018-07       Impact factor: 1.730

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.